Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NewJerichoMan...float/liquidity......
Do you have a rule of thumb about what % of the float not to exceed? I recently noticed I owned about 5% of the float on a low liquidity shell and it made a bit uneasy. If that trade goes sideways, I'm going to get eviscerated on the exit. Lol.
That would be a $1.59 solid
No Rush! See ya in March
Regards
What's the rush, been ready for years lol
MR ready plans to finalize are in motion as per Surfbear
Get ready
Regards
In ASKH terms Mr Adder sir?
Interesting. $1M has been pretty much my benchmark on Shell value although lately, finding sub-$1M valuations has become much easier.
Regarding FWFW: If the reverse merger gets officially completed and I am correct in the legacy share count being under 1.6M shares, I think FWFW would have a pretty decent chance of seeing at least $3-5M on those legacy shares. So I am semi-expecting to get at least $2-3 on my position.
Wake up MR -
Regards
NewJerichoMan...legacy share valuation.....
Quick aside, I'm trying to understand why you are taking legacy shares into account when evaluating the market cap. Could you explain why one would analyze one's DCA in this manner?
But focusing on the current numbers/valuation, the upside potential from this 5-cent level is pretty hard for me to ignore. Using the full 16M shares as a legacy base number gives ADMG around an $800K legacy valuation at the current 5 cents. There usually is the potential for decent money to be made when you can buy a relatively attractive shell at a legacy valuation under $1M. What makes ADMG even more interesting/attractive to me is the possibility of Eastland selling some or all of his position to the RM target. In that best-case scenario, ADMG's legacy valuation at 5 cents could be under $220K.
Right sector = proper profit ASKH
Askh for $4.59
Lmao - yeah he’s maxed out
:(((((((((( Hes had 2 terms lol
Times up!
Close a damn deal!
Regards
You know that political chant 4 more years lol
Dont say that our # is 22 latest 23
Regards
‘24 is supposed to be THEE year
Lets close a deal !!!!!!!!!! $ASKH
Regards
Music to my ears Mr Adder sir
Our gem ASKH posts a Hot Sector merger and that $1.59 is very doable given the OS is only 30 mil.
That MGUY merger is a rehash of 2 years ago and another logistics company.
In ASKH terms, Mr Adder sir?
Both ZNNC and FWFW look like interesting prospects.
FWFW seems more intriguing at the moment. Float looks locked up really tight though.
Quick aside, I'm trying to understand why you are taking legacy shares into account when evaluating the market cap. Could you explain why one would analyze one's DCA in this manner?
The legacy share count appears to be under 1.6M shares, so at my current average I bought at a legacy share valuation of under $610K on this shell/RM.
FWFW(.50)...accumulated a position......
17.75M shares outstanding
451K unrestricted shares
Accumulated shares from the sub-20 cent level to 50 cents. I found it extremely difficult to get any sizable amount of shares under 20 cents, so I decided to be a little more aggressive when I saw the ask price drop under 40 cents. Currently averaged in under 39 cents.
Roy Tang purchased control of the shell in July of 2021 for the purpose of bringing his Asia-based financial services firm public (Flywheel Financial Strategy). Around mid-December of 2021, Flywheel had a listing ceremony/celebration (as per the company website), and from that time forward the company has identified itself as an OTC-listed company. The problem is that the Flywheel SEC filings still do not show the reverse merger (movement of Flywheel's assets/liabilities into the shell) has officially occurred yet. So that is the primary risk on this play.
I am working under the assumption that this RM will become official at some point. I think the CEO has a pretty strong desire to eventually have this company listed on the Nasdaq. Unless there is some extremely negative change in the final structure (which is certainly possible here), the risk/reward around these prices looks very interesting to me. The legacy share count appears to be under 1.6M shares, so at my current average I bought at a legacy share valuation of under $610K on this shell/RM.
https://flywheelfs.com/
https://www.youtube.com/channel/UCa2ijfjV3cLBw-eakqvX8Pg
https://www.facebook.com/financialeliteHK
HOOD lod $9.21 buy buy buy
ZNNC(.0022)...added to position......
Let me preface this post by stating that ZNNC is probably a mess of a company (in a number/variety of ways), so the risk level is pretty high. Transparency and providing investors with a clear/coherent picture of the company has never been one of ZNNC's strong points. Japanese OTC companies have pretty much always been a nightmare to research/understand (speaking for myself), so I don't spend a great deal of time trying to analyze them, and ZNNC is certainly no exception.
I think that‘s gotta be a mistake somehow, I think this might be a done merger now and the shares added should be restricted but we will see. Just a thought. They have no notes or anything, where should these unrestricted come from suddenly? There are preferreds out there, that could be a possibility I guess.
Setting up for one heck of a January
Probably going to workout like the Cowboys playoff run.
Speaking of which, the way things are trending, Dallas probably gets another shot at San Fran in the playoffs this year. It'll be important, Dallas wins they probably take the lead on most playoff wins in SB era lead. If they lose... well, time for some soul searching for Jerry.
It will matter when you find yourself sitting in a FEMA Camp.........lol
Z
#DDAmanda Video Analysis of: $APSI
Assuming there is volume for them to get absorbed by the market, could be a RS is around the corner, IMHO.
Hope it works out.
If a R/M shell you're holding suddenly issues 90M new unrestricted shares, is that a bad thing?
Wish I was asking for a friend.
NBLD .034------------------->$2.78 in 2 sessions on RM PR
KPEA(.20)...CEO interview...acquisitions, Nasdaq uplisting......
China Fortune.com (China Fortune Media Group) did a 6-minute interview/feature on KPEA and its CEO last week. The video doesn't have a closed caption feature, but it looks like much of the final 2 minutes of the interview was about the stock. The article text that accompanies this video seems to make it pretty clear that KPEA still has intentions of uplisting to the Nasdaq at some point. It looks like the company is viewing the upgrade to QB status as just a stepping stone toward its eventual goal of trading on the Nasdaq. Recent internally-generated material that the company has posted on its website, and other recent third-party articles also reiterate KPEA's continued desire to eventually uplist to the Nasdaq.
The interview/article mentions that KPEA intends to complete the acquisition of at least one of the two target companies by the end of this year. So I would probably expect to see some increase in corporate activity over the next few months or so.
Some noteworthy items from the interview/article......
On May 17, 2021, Kunpeng (China) was successfully listed on the OTC market in the United States through a reverse merger. After a lapse of one year, Kunpeng (China) Overseas Holdings Co., Ltd. passed layers of audits and successfully transferred to the OTC QB board in the United States.
Talking about the impact of the capital market on Kunpeng’s business development, Zhai Xin said that since entering the capital market for more than a year, Kunpeng (China) has been expanding the company’s financing channels, improving the company’s capital structure, standardizing the corporate governance structure and improving The company has made considerable progress in terms of the liquidity of its shares, which also laid the foundation for the next transfer to the NASDAQ main board in the United States. At the same time, through the empowerment of capital, Kunpeng (China) will accelerate the development process of the offline entity Kunzhijian·Healthy House.
In September 2022, Kunpeng (China) will start its acquisition and merger business. It is planned to acquire 1-2 high-quality companies and integrate them into the capital system of Kunpeng (China) by the end of the year. Zhai Xin said that Kunpeng (China) is looking for excellent supply chain companies to carry out in-depth cooperation with them to achieve rapid business development and drive up the company's market value and valuation. At the same time, Kunpeng (China) is also committed to helping cooperative enterprises grow rapidly and share the feast of capital.
In terms of capital operation and maintenance, Kunpeng's capital team will provide acceleration for Kunpeng's capital development with high-dimensional professionalism, high-tech technology, and multi-dimensional operability. At the level of the plan to transfer to the NASDAQ main board in the United States, we look for excellent supply chain companies and conduct in-depth cooperation with them to achieve the rapid development of Kunpeng (China)'s business and drive up the company's market value and valuation. At the same time, help cooperative enterprises grow rapidly and share the feast of capital.
thank you. I have put HLTT on my radar
nsomniyak...HLTT's Q4 revenue......
What HLTT did not say was whether the revenue would be recurring or not. THey indicated that for the to acquire a company already generating revenue wa not be be expected.
We expect HWC’s wound care business to become profitable during the fourth quarter of 2022, which will alleviate some of the cash flow burden of that business. That revenue, occurring shortly after our acquisition of the wound care business, will likely be the exception to the norm for our portfolio companies. Our business plan contemplates that, to attract exciting additions to our portfolio, we will offer most the several million dollars of financing that is necessary to bring a medical technology to a stage where its sponsor can function independently. Since our ambition is to sustain a portfolio of such enterprises, our near term capital requirements (near term being the two to three years before we can anticipate initial returns on most of our investments) will be tens of millions of dollars.
We expect that the manufacture and sale of allografts by HWC will become profitable in the foreseeable future. Our business plan, however, contemplates a breadth of operations in addition to wound care treatments. For that reason, our research and development expenses will rise significantly if we obtain the capital resources necessary to fully implement our business plan. In particular, expansion of the operations of HWC to include additional product lines and the effort to bring MediScan’s and RevHeart’s technology to market will require several million dollars of capital expense. For that reason, we cannot predict when we will achieve company-wide profitability.
We expect HWC’s wound care business to become profitable during the fourth quarter of 2022, which will alleviate some of the cash flow burden of that business.
What HLTT did not say was whether the revenue would be recurring or not. THey indicated that for the to acquire a company already generating revenue wa not be be expected.
NBLD on RM PR .034----------->.895
Followers
|
178
|
Posters
|
|
Posts (Today)
|
2
|
Posts (Total)
|
5927
|
Created
|
02/02/12
|
Type
|
Free
|
Moderator Involuntary-Recluse | |||
Assistants TURCH puffadder |
Identify and target the following opportunities:
Posts Today
|
2
|
Posts (Total)
|
5927
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |